Mid week snips | Biotech Message Board Posts


  • Get 3 months of ad-free premium service for every $25 you contribute
    to support critical site improvement efforts.
    With no recurring subscription
    to worry about, this an ideal way to test drive our premium service.

    Premium features, such as multi-message viewing (i.e., being able to open
    up to 100 messages with a single click) can save you lots of time
    over the course of a busy day, to say nothing of an entire year!
    Watch this 2-min video to see why premium is right for you.


    *Offer expires at midnight

Biotech   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  27594 of 28416  at  6/19/2019 8:10:46 AM  by

minxmrphd


 In response to msg 27593 by  minxmrphd
view thread

Re: Mid week snips

 

$SRNE Sorrento Therapeutics Announces Positive Results of Phase 1b Resiniferatoxin (RTX) in Knee Osteoarthritis Pain Trial

$MLNT FDA Accepts sNDA for BAXDELA for the Treatment of CABP. Grants Priority Review. PDUFA 10/24/19

$SESN offering. 20M shares + warrants at $1.47/share

$AKTX announces positive results for Part A of TRACKER Phase I/II clinical trial evaluating the safety and efficacy of topical nomacopan in moderate to severe atopic keratoconjunctivitis (AKC).



     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 6     Views: 174
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...